TickerFacts.

Sigyn Therapeutics, Inc. (SIGY): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-40, first reflected in a filing dated 2024-02-20. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.33M
Year ended 2024-12-31
81.27M2014-12-31: 27.95M2015-12-31: 30.99M2017-12-31: 47.09M2018-12-31: 65.07M2019-12-31: 81.27M2020-12-31: 7.35M2021-12-31: 36.40M2022-12-31: 934.9K2023-12-31: 1.10M2024-12-31: 1.33M1.33M
2014-12-31 Weighted Average Diluted Shares (shares) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2024-12-311.33M+21.1%2025-04-15, From 2024-01-01
2023-12-311.10M+17.7%2025-04-15, From 2023-01-01
2022-12-31934.9Kn/c2024-02-20, From 2022-01-01
2021-12-3136.40Mn/c2023-03-31, From 2021-01-01
2020-12-317.35M-91.0%2022-03-21, From 2020-01-01
2019-12-3181.27M+24.9%2020-03-30, From 2019-01-01
2018-12-3165.07M+38.2%2020-03-30, From 2018-01-01
2017-12-3147.09Mn/c2019-04-01, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-3130.99M+10.9%2016-03-30, From 2015-01-01
2014-12-3127.95Mn/a2016-03-30, From 2014-01-01